HomeHealth articlesmenopauseWhat Is Lobular Endocervical Glandular Hyperplasia?

Lobular Endocervical Glandular Hyperplasia - An Overview

Verified dataVerified data
0

4 min read

Share

Lobular endocervical glandular hyperplasia is a rare benign glandular proliferation commonly affecting premenopausal women. Read on to learn more.

Written by

Dr. Aysha Anwar

Medically reviewed by

Dr. Sangeeta Milap

Published At April 29, 2024
Reviewed AtApril 29, 2024

Introduction:

A rare benign glandular proliferation commonly affecting premenopausal women is called lobular endocervical glandular hyperplasia (LEGH). Germinal mutations in the STK11 gene and Peutz-Jeghers syndrome are linked to LEGH. Well-demarcated multicystic masses with watery vaginal discharge are unusual, although they typically present as an accidental observation. Under the microscope, LEGH reveals a lobular architecture with numerous tall mucinous glands and pale cytoplasm, similar to the pyloric gastric glands. This illness is the benign variety of endocervical glandular lesions of the gastric type.

What Is the Uterine Cervical Lobular Endocervical Glandular Hyperplasia?

Endocervical glands, which are abnormally abundant in the cervix, are the hallmark of the benign disorder known as Lobular Endocervical Glandular Hyperplasia (LEGH) of the uterine cervix. The pattern seen under a microscope is used to diagnose this particular form of glandular hyperplasia.

Lobular endocervical epithelial hyperplasia of the cervical region exhibits the same morphological characteristics as the stomach pyloric glands. Both premenopausal and postmenopausal women experience the disease. However, some experts think that LEGH of the cervix may be a premalignant syndrome because it is linked to cancers like adenocarcinoma in situ, adenoma malignum of the uterine cervix, and several types of cervical cancer.

What Other Names Does This Condition Go By?

  1. Hyperplasia of the cervical lobular endocervical glandular.

  2. LEGH of the cervical uterus.

  3. Metaplasia of the pyloric gland in the uterine cervix.

What Are the Risk Factors for Uterine Cervical Lobular Endocervical Glandular Hyperplasia?

  • No clear-cut risk factors are known for lobular endocervical epithelial hyperplasia of the uterine cervix.

  • Women with Peutz-Jeghers syndrome have been documented to exhibit certain cases of LEGH of the cervix.

  • It is crucial to understand that a risk factor does not guarantee the development of the illness. A person with a risk factor has a higher probability of developing a condition than a person without that risk factor. Certain risk variables carry greater significance than others.

  • The absence of a risk factor does not guarantee that a person will develop the illness. It is imperative to have a conversation with healthcare practitioners about the impact of risk factors.

What Causes Uterine Cervical Lobular Endocervical Glandular Hyperplasia?

  • The precise etiology and mechanism of lobular endocervical epithelial hyperplasia of the uterine cervix are unknown.

  • Certain aberrant characteristics of the uterine cervix have been shown in studies to exhibit chromosomal abnormalities in the LEGH.

  • It is unknown if the illness is linked to an HPV (human papillomavirus) infection.

What Are the Signs and Symptoms of Uterine Cervical Lobular Endocervical Glandular Hyperplasia?

  • One may observe the subsequent indications and manifestations of lobular endocervical glandular hyperplasia of the uterine cervix:

  • An atypical vaginal discharge, or a discharge of mucus or water, may result from the disorder.

  • On imaging examinations, a bulk may occasionally be detected. In certain situations, the mass may resemble a cyst. When examined visually, LEGH is shown to be clustered around a sizable central gland that exhibits characteristics of benign stomach glands (pyloric type gastric glands).

  • Most lesions show no discernible signs or symptoms and are asymptomatic.

How Is Uterine Cervical Lobular Endocervical Glandular Hyperplasia Diagnosed?

The following procedures may be necessary for a diagnosis of lobular endocervical glandular hyperplasia of the uterine cervix:

  • Ultrasound scan of the abdomen CT or CAT scan with contrast of the abdomen and pelvic.

  • Using this radiological technique, intricate three-dimensional images of inside body structures can be produced.

  • MRIs of the Pelvis and Abdomen: Magnetic resonance imaging (MRI) uses a magnetic field to produce high-quality images of specific bodily areas, including tissues, muscles, nerves, and bones. These excellent images might demonstrate the mass's existence.

  • Colposcopy: The colposcope is a tool used to inspect the cervix. This facilitates the doctor's ability to see the cervix more clearly.

  • Biopsy of the Cervical Region: It is the procedure where tissue is taken out for analysis. A total excision and removal of the mass can aid in the biopsy procedure and serve as a treatment option for lobular endocervical glandular hyperplasia. Under a microscope, a pathologist examines the tissue sample to check for any signs of malignancy. Cervical biopsies come in various forms.

  • Colposcopic Biopsy: A colposcopy is used to view the abnormal parts of the cervix. Once the cervix has been numbed with a local anesthetic, a biopsy forceps is used to remove a sample of tissue. Following the surgery, there may be some little bleeding, mild cramping, and soreness.

  • Endocervical Curettage: This is also known as endocervical scraping, a technique that involves using a curette to remove tissue. Under a microscope, cells are removed using a curette from the endocervix, the inner portion of the cervix closest to the uterus or womb. Following the surgery, there may be some little pain and bleeding.

What Are the Potential Consequences of Uterine Cervical Lobular Endocervical Glandular Hyperplasia?

  • Since lobular endocervical glandular hyperplasia of the cervix is often benign, significant consequences are rarely seen.

  • Adenocarcinomas or precancers have been linked to a small number of cases.

What Is the Treatment for Lobular Endocervical Glandular Hyperplasia of the Uterine Cervix?

The following are possible courses of treatment for lobular endocervical glandular hyperplasia of the uterine cervix:

  • Complete excision during surgery can lead to a full recovery.

  • Following surgery, care is crucial: Maintaining a minimum level of activity while the surgery wound heals is necessary.

  • Regular screenings and check-ups as part of follow-up care are crucial.

What Is the Prevention Strategy for Lobular Endocervical Glandular Hyperplasia of the Uterine Cervix?

  • There is currently no way to avoid lobular endocervical glandular hyperplasia of the uterine cervix.

  • It is recommended that routine medical screening with scans and physical exams be performed.

What Is the Prognosis for Uterine Cervical Hyperplasia of the Lobular Endocervical Glandular Hyperplasia?

  • Since lobular endocervical glandular hyperplasia of the uterine cervix is usually a benign lesion, the prognosis is excellent with surgical intervention and total excision.

  • Very few occurrences of high-grade cervical glandular intraepithelial neoplasia (HG-CGIN) or adenocarcinoma in situ (AIS) coexist with cervical LEGH.

  • A thorough inspection of the surrounding tissue is required since they could be connected to minimal deviation or stomach-type cancer.

Conclusion:

A multicystic tumor in the upper cervix with a watery discharge is the clinical manifestation of LEGH, an uncommon and benign entity with a gastric immunophenotype. With this group of symptoms, caution is advised because the primary diagnosis is “GAS,” and it may be difficult to distinguish it from LEGH. Atypia, typically present in GAS, at least focally; lobular configuration, which is unique to LEGH; and lesion limits, which are well defined in LEGH but not in GAS, are some characteristics that help distinguish the two entities.

Source Article IclonSourcesSource Article Arrow
Dr. Sangeeta Milap
Dr. Sangeeta Milap

Obstetrics and Gynecology

Tags:

lobular endocervical glandular hyperplasiamenopause
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

menopause

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy